Global body composition analyzers market accounted for $356 million in 2017 and is estimated to reach $596 million by 2025

By -

 As per the report published by Allied Market Research, the global body composition analyzers market accounted for $356 million in 2017 and is estimated to reach $596 million by 2025, registering a CAGR of 6.6% from 2018 to 2025. The report provides an extensive analysis of drivers & opportunities, key winning strategies, market size & projections, major segments, and competitive landscape.

Rise in obese population, supportive initiatives by governments for promoting healthy lifestyle, and increase in health consciousness among people drive the growth of the market. However, high cost of investment and stringent regulations related to usage of body composition analyzers restrain the market growth. On the other hand, upsurge in the number of gyms and fitness clubs would create new opportunities in the industry.

The bio-impedance analyzer segment held the major share, accounting for more than two-fifths of the total share in 2017 and is estimated to maintain its dominance during the forecast period. This is due to lower cost and convenience offered by them in comparison to other analyzers. However, the air displacement plethysmography equipment segment is expected to grow at the largest CAGR of 9.6% from 2018 to 2025, owing to increase in accuracy provided by these equipment and surge in awareness regarding bod pods.

The fitness clubs & wellness centers segment held a major share, contributing for more than two-thirds of the total share in 2017, and is estimated to maintain its pole position by 2025. This is attributed to surge in health consciousness among population and considerable surge in number of health clubs and gyms worldwide. However, the home user segment is expected grow at the largest CAGR of 10.4% during the forecast period, owing to rise in adoption of handheld and portable body composition analyzers for gaining convenience and flexibility in use.

North America held the major share with nearly two-fifths of the share of the market in terms of revenue in 2017 and is estimated to continue its leadership status by 2025, owing to presence of advanced healthcare infrastructure and ongoing R&D initiatives. However, Asia-Pacific is expected to register the highest CAGR of 9.0% from 2018 to 2025, owing to the rise in healthcare expenditure, increase in fitness clubs & wellness centers, and surge in obese population in developing countries.

The key market players discussed in the report include Omron Corporation, Hologic, Inc., Cosmed S.R.L., GE Healthcare, Jawon Medical Co., Ltd., Tanita Corporation, Rjl Systems, Inc., Inbody Co., Ltd., Bodystat Ltd., and Seca GmbH & Co. Kg. They have adopted different strategies such as partnerships, expansions, mergers & acquisitions, joint ventures, collaborations, and others to gain a strong position in the industry.

Read More @ https://www.alliedmarketresearch.com/press-release/body-composition-analyzers-market.html

Comments

Post a Comment

Popular posts from this blog

Global Cancer pain market is segmented based on drug type, disease indication, and region.

By -
According to a new report published by Allied Market Research, titled, "Cancer Pain Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"  the global cancer pain market was valued at $5,285 million in 2017, and is expected to reach $7,545 million by 2025, growing at a CAGR of 4.5% from 2018 to 2025. Download the Sample Report @  https://www.alliedmarketresearch.com/request-sample/5123?utm_source=Blogger&utm_medium=Niranjan Cancer pain is chronic in nature and is commonly associated with cancer. It results from tissue damage, either due to the disease itself or due to different treatments such as chemotherapy, radiotherapy, or surgery. Cancer pain drugs are expected to exhibit significant market growth during the forecast period due to growth in demand for the drugs, surge in prevalence of cancer across the globe, increase in number of R&D activities to develop ideal cancer pain medications, and rise in the unmet nee...
Read more

U.S. was the largest country market in 2015, and is projected to maintain its lead until 2022.

By -
Image
  Surge in usage of wireless monitoring devices and increase in population of aging people across the globe drive the growth of the global patient monitoring devices market. However, high cost associated with patient monitoring devices is anticipated to restrain the market growth. Furthermore, increasing technological advancements are expected to provide new opportunities during the forecast period. The  Patient Monitoring Devices Market  generated $25.76 billion in 2019, and is estimated to reach $44.86 billion by 2027, registering a CAGR of 4.4% from 2020 to 2027. Based on product type, the cardiac monitoring devices segment contributed to the largest share in 2019, accounting for more than one-fourth of the total share, and is estimated to maintain its dominant position during the forecast period. However, the remote patient monitoring devices segment is estimated to portray the highest CAGR of 6.3% during the forecast period. Based on end-user, the hospitals segment a...
Read more